- Sweden’s EQT AB and Goldman Sachs Group Inc’s (NYSE:GS) investment arm are reportedly negotiating the acquisition of contract-research organization Parexel International Corp for nearly $9 billion, including debt.
- Parexel offers a suite of biopharmaceutical services for clinical trials to regulatory, consulting, and market access.
- Currently, Pamplona Capital Management owns Parexel.
- According to Wall Street Journal, a sale to EQT and Goldman could be completed this week, assuming talks don’t fall apart, the people said.
- The business had drawn interest from both private equity and strategic bidders.
- Price Action: GS shares closed at $374.99 on Thursday.
DA Davidson Maintains Buy on Coinbase Global, Lowers Price Target to $70
DA Davidson analyst Christopher Brendler maintains Coinbase Global (NASDAQ:COIN) with a Buy and lowers the price target from $100 to $70.
